Clinical trials
Phase 1 Multiple Endocrine Neoplasia Type 1 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| GlaxoSmithKline | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Medical College of Wisconsin | 1 |
| Syracuse University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Endocrine Neoplasia Type 1 | 7 |
| Hot Flashes | 2 |
| Eunuchism | 1 |
| Hypogonadism | 1 |
| Meningioma | 1 |
| Neuroendocrine Tumors | 1 |
| Postoperative Pain | 1 |
| Prostatic Neoplasms | 1 |
| von Hippel-Lindau Disease | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.